Ms. Steenhuysen was a panelist for the Forum’s discussions on Alzheimer’s: What is the value of knowing early? and The Zika Crisis.
Julie Steenhuysen has been covering health and science topics for Reuters for the past decade, first as a medical device correspondent, then as team leader for the equities team covering U.S. pharmaceuticals and healthcare companies. For the past 4 years, Julie has worked as U.S. health and science correspondent, focusing on coverage for a general news audience.
